SCHEMBL6993223

SCHEMBL6993223

CCOC(=O)c1ccc(CCC(CO[Si](C)(C)C(C)(C)C)OS(C)(=O)=O)s1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ERN1 O75460 1/20 0.32
CDC7 O00311 1/20 0.31
DBF4 Q9UBU7 1/20 0.31
AR P10275 1/20 0.31
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
JAK3 P52333 1/20 0.30
KDM4E B2RXH2 1/20 0.30
P2RY1 P47900 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993227 1.00 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6993503 0.85 HDAC3 (0.33) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6993500 0.85 HDAC3 (0.33) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990850 0.83 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990853 0.83 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990485 0.83 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990488 0.83 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL8684857 0.80 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2GAAMAPTL3MBTL1
SCHEMBL6996040 0.78 SERPINE1 (0.39) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6996037 0.78 SERPINE1 (0.39) HDAC3HDAC4HDAC1HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed